SKAN Group AG Investor Presentation September 2023

SKAN Group AG presented an investor overview of contamination risks in biopharmaceutical manufacturing. The presentation covers key safety challenges in pharmaceutical production, including air particles, raw materials, and personnel contamination sources across injectable drugs, cancer therapies, cell & gene therapy, vaccines, and hormone products.